NICE technology appraisal guidance
Issued: September 2009
TA181
Pemetrexed for the first-line treatment of non-small-cell lung cancer
This is an extract from the guidance. The complete guidance is available at guidance.nice.org.uk/ta181
Changes after publication
March 2012: minor maintenance